A Phase II Trial Of IRESSA (NSC 715055, IND 61187) In Combination With 5-FU/LV/ CPT-11 In Patients With Advanced Or Recurrent Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2013
At a glance
- Drugs Gefitinib (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 15 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 29 Oct 2007 Status changed from in progress to completed.